Dr. CHEKITAAN SINGH

Dr. REENA GUPTA, Dr. PRADEEP TEKWANI, Dr.Ishwar Singh

Abstract

COVID-19 pandemic poses new challenges for patients & caregivers in terms of limited follow-ups, need for shorter, safer & predictable treatments. Micro Pulse Trans scleral Laser Therapy (MP-TLT) has demonstrated efficacy in lowering intra-ocular pressure (IOP) across glaucoma types in published studies. We treated 10 eyes (9 patients) with uncontrolled glaucoma (Angle closure, Secondary, Neovascular, Failed Trab., Developmental & ICE syndrome) with MP-TLT (Power:2000mw, Duration:160s, Duty cycle:31.3%), from March – June 2020. Age ranged from 17-80 years,5 males & 4 female patients, Pre-op IOP ranged from 14-53mmHg (mean27.33). Patients followed up at 1 day, 1 week & 1 month. At 1 month follow-up, decrease in IOP ranged from 4-44mmHg, reduction in IOP ranged from 28.5% -83% from baseline & mean number of medications used decreased from 3.4 to 2.4. MP-TLT is suited in COVID times as quick, effective, safe, non-invasive technique, needing minimum post op visits for treating glaucoma.